- 8017 Labana Ct, Canton Township, MI 48187
- +1 (734) 418 2537
- info@a2zbillings.com
A urologist places a UroLift implant in the office, sees that same patient back two weeks later for an unrelated urinary tract infection, and performs the identical device procedure the following month at a hospital-owned surgery center. Three encounters, three different billing rules. A2Z Billings tracks which code set, modifier, and site-of-service rule applies to each one, so reimbursement doesn’t depend on when or where the service happened to take place.
Urology reimbursement shifts with the setting as much as with the procedure itself. A device implanted in the office follows a different code set than the same device placed at a hospital-owned facility. A follow-up visit inside a 90-day global period needs a specific modifier to be paid at all, and a handful of common procedures sit close enough to the line between covered and elective that the wrong assumption turns into a denial. Getting paid consistently means tracking site of service, global-period timing, and payer-specific medical necessity rules side by side.
Each of these runs on its own rule set: global surgery bundling, diagnostic test bundling, site-of-service coding, and coverage rules for procedures that sit near the line between medically necessary and elective. Applying one rule where another belongs is where most denials start.
Most major urologic surgery carries a 90-day global period, and related postoperative care is bundled into the original surgical fee. A visit for something unrelated, such as a urinary tract infection after a prostatectomy, is billable on its own, but only with modifier 24 attached and a diagnosis that clearly shows it's unrelated to the surgery. A procedure staged at the time of the original surgery needs modifier 58 instead, and an unrelated procedure needs modifier 79.
A complex cystometrogram already accounts for the pressure and flow measurements that a simple study captures on its own, so reporting a simple uroflowmetry or cystometrogram alongside a complex study from the same session runs into NCCI bundling edits. Documentation needs to specify which channels were actually recorded, since that's what determines the single code that applies.
Prostatic urethral lift and water vapor thermotherapy are increasingly done in the office, but the same device procedure performed at a hospital-owned outpatient facility uses a different billing structure, with the facility capturing a separate device charge. Billing the office code in a facility setting, or missing the facility-side device charge, leaves money on one side of the claim or the other.
Circumcision beyond infancy, vasectomy reversal, and testosterone therapy without qualifying labs are only covered when a documented condition supports them; without that, they default to a patient-pay service. Submitting them to insurance as routine care, without a supporting diagnosis or a signed Advance Beneficiary Notice on file, produces a denial that then has to be moved to the patient after the fact instead of before it.
A handful of mistakes account for most of the denials we see in urology claims, and they repeat across practices until the underlying workflow is fixed.
Billing a postoperative E/M visit without modifier 24 and a distinct diagnosis, which gets it bundled into the original surgery instead of paid separately.
Billing a simple cystometrogram or uroflowmetry alongside a complex study from the same session, when the complex code already includes that work.
Applying the in-office code to a facility-based UroLift or Rezum procedure, or the reverse.
Billing without a diagnosis such as recurrent balanitis or phimosis on the claim, which reads as elective without it.
Sending vasovasostomy claims to a payer that excludes infertility-related procedures, without confirming the plan's exclusion language first.
Requesting authorization for onabotulinumtoxinA without documenting a completed trial of oral therapy, which most payers require first.
Billing one ester under the code written for another, or leaving off the administration code for the injection itself.
Urology claims that touch a global period, a device, or an elective-adjacent procedure need documentation built for that specific rule, not a general operative note.
Which urology services need prior authorization, and what a payer wants to see before approving them, changes from one plan to the next. A device procedure approved automatically under one policy needs a peer-to-peer review under another, and a medication trial that satisfies one payer may not satisfy the next.
When a service like vasectomy reversal, elective circumcision, or testosterone therapy without qualifying labs is likely to fall outside coverage, an ABN sets expectations with the patient before the procedure happens. A2Z Billings checks medical policy and benefit terms ahead of scheduling, so the practice and the patient both know where a claim is headed before it's submitted.
A urology claim can move through a global period, a site-of-service rule, and a coverage determination before it's ever submitted. Each step in the cycle has to account for that instead of treating every claim the same way.
Confirms device, drug, and procedure coverage, including plan-specific medical policy, before the appointment is scheduled.
Applies the correct site-of-service code and global-period modifier at the point documentation is finalized.
Targets bundling edits, missing modifiers, and medical-necessity denials on elective-adjacent claims directly.
Reconciles facility-side device payments and moves confirmed non-covered balances to patient billing promptly.
We work from the operative note and visit documentation to apply the modifier a global period actually calls for, match a device procedure to the code set for the site where it happened, and confirm medical necessity before an elective-adjacent service is scheduled rather than after it's denied.
Most likely because it was billed without modifier 24, or the diagnosis didn't clearly show it was unrelated to the original surgery. Medicare and most commercial payers bundle related postoperative care into the surgical fee for 90 days on major procedures, so an unrelated visit needs both the modifier and a distinct diagnosis to be paid separately.
No. The same device procedure uses different billing structures depending on where it happens. In the office, the practice bills the procedure code and generally absorbs the device cost. At a hospital-owned outpatient facility, the facility bills separately for the device, and the codes on each side of that claim differ from the office version.
Yes. Payers generally want to see a completed trial of oral anticholinergic or beta-3 agonist medication before approving onabotulinumtoxinA, so we confirm that documentation is in place before submitting the authorization request, and we track the dose against the units billed under J0585.
It depends on the patient's age and the reason for the procedure. Newborn circumcision follows its own codes and is usually covered under the birth admission. Circumcision performed later, for a condition such as recurrent balanitis or phimosis, can be billed with a supporting diagnosis. Without a medical indication, it's an elective service and should be handled with a signed ABN rather than submitted as routine care.
A complex cystometrogram already includes the measurements a simple cystometrogram or uroflowmetry would capture on their own, so NCCI edits remove the simpler code when it's billed alongside the complex one from the same session. The study should be billed as the single code matching the channels actually recorded, not as a stack of individual components.
Usually not. Most commercial and Medicaid plans classify vasovasostomy as an infertility-related procedure and exclude it from coverage, though the exact language varies by plan. We verify the specific exclusion before scheduling and put a signed ABN in place when the service is likely to be denied, so the patient isn't billed as a surprise afterward.
